scispace - formally typeset
A

Alexander T. Mameghani

Researcher at University of Basel

Publications -  6
Citations -  62

Alexander T. Mameghani is an academic researcher from University of Basel. The author has contributed to research in topics: Odds ratio & Synostosis. The author has an hindex of 3, co-authored 6 publications receiving 51 citations. Previous affiliations of Alexander T. Mameghani include University Hospital of Basel.

Papers
More filters
Journal ArticleDOI

Complications and cancer rates in spine fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2).

TL;DR: rhBMP-2 is associated with a higher rate of general complications as well as retrograde ejaculation, HO, and cervical tissue swelling in spine fusion, and there is a slightly increased risk of new onset of tumors, however, without statistical significance.
Journal ArticleDOI

Complications and Cancer Rates in Spine Fusion with Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)

TL;DR: To quantitatively synthesize the available best evidence for general complications, heterotopic ossification (HO), retrograde ejaculation, cervical swelling, and cancer rates with the use of rhBMP-2 in lumbar and cervical spine fusion.
Journal ArticleDOI

Platelet concentrates in spine fusion: meta-analysis of union rates and complications in controlled trials

TL;DR: The use of platelet concentrates in spine fusion shows significantly decreased union rates compared with the control group, however, complication and revision rates were not significantly increased and the current data do not recommend the use of Platelet concentrate in spine Fusion.
Journal ArticleDOI

Synostosis of the sacroiliac joint as a developmental variant, or ankylosis due to sacroiliitis?

TL;DR: The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target and a possible therapeutic target.
Journal ArticleDOI

Union Rate and Complications in Spine Fusion with Recombinant Human Bone Morphogenetic Protein-7: Systematic Review and Meta-Analysis

TL;DR: The current best evidence to assess effectiveness and safety of recombinant human bone morphogenetic protein-7 (rhBMP-7) as a biological stimulant in spine fusion was not able to find, and there was no evidence for increased complication or revision rates with rhB MP-7.